James H. Cavanaugh, Director, 10% Owner at PHARMATHENE, INC (HAQ), bought 3,192,243 shares at $7.66 ($958K) on 2007-08-03, disclosed to the SEC on 2007-11-13.
Open-market purchase of $958k HAQ by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,067,243 | $0 | 0.0% |
| 2 | $7.66 | 125,000 | $958K | 100.0% |
| Total | $0.30 avg | 3,192,243 | $958K | 100% |
| Filing → |
| VRNM | BUY | 2011-08-16 | $105K | — | Filing → |
| VRNM | BUY | 2011-08-15 | $37K | — | Filing → |
| VRNM | BUY | 2011-03-16 | $79K | — | Filing → |